Developer docs
API playgroundTry for free, no card

Search company profiles

Aegis Sciences

Full company profile

uuid0000yyr

Namestring
Aegis Sciences
Legal namestring
Aegis Sciences Corporation
Websiteurl
aegislabs.com
Company typeenum
Private
Founded yearint
1990
Descriptiontext

Aegis Sciences Corporation is a privately held forensic toxicology and clinical laboratory founded in 1990 and headquartered in Nashville, Tennessee. The company performs definitive drug and substance testing on urine, oral fluid, and blood specimens using liquid chromatography-tandem mass spectrometry (LC-MS/MS) under CLIA and College of American Pathologists (CAP) standards, and serves a diverse set of customers including pain management providers, behavioral health and substance use disorder treatment providers, professional and amateur sports organizations, pharmaceutical companies, and public health agencies.

The company's product portfolio is organized around branded clinical offerings: PainComp and AcuRise ID for adherence monitoring; a continuously updated Novel Psychoactive Substances (NPS) testing menu aligned with CFSRE/SOFT recommendations; the NPS Insights Dashboard providing real-time national surveillance visualization; InterACT Rx for drug-drug interaction detection (co-developed with QURE); BioDetect; Kratom Alkaloids and expanded Cannabinoid testing; Clinical Blood Testing; Infectious Disease Testing; and the Zero-Tolerance anti-doping service operated out of the Wilma Rudolph Sports Testing Laboratory, where Aegis is the largest independent anti-doping laboratory in the U.S. serving more than 150 colleges, universities, high schools, and professional sports organizations. CareEvolve is the client-provider portal for test ordering and results delivery.

Aegis generates revenue on a per-test basis, billed primarily through Medicare, Managed Medicaid, Commercial Insurance, and Workers' Compensation, with the UnitedHealthcare Preferred Lab Network relationship expanding in-network access. Go-to-market is sales-led, directed at healthcare providers who order testing through the Aegis platform, supplemented by clinical education content, webinars, the NPS Insights Dashboard, and conference participation. In June 2025 the company completed a $170 million debt refinancing to support continued investment in laboratory infrastructure and service expansion.

Short descriptiontext

Aegis Sciences Corporation is a Nashville-based forensic toxicology and clinical laboratory that performs definitive LC-MS/MS drug and substance testing on urine, oral fluid, and blood for healthcare providers, sports organizations, biopharma companies, and public health agencies across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
forensic toxicology laboratory, clinical drug testing, medication adherence monitoring, novel psychoactive substances, anti-doping testing services
Industry4 codes
PRIMARYHLAFAMAF
Toxicology & Therapeutic Drug Monitoring Laboratories
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGACAK
Clinical Trial Pharmacy & IMP Management at Site
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
NAICS code4 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Forensic Toxicology and Clinical Drug Testing Laboratory Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Drug Testing Services
TypeSubscription Recurring
Description

Healthcare providers order definitive drug testing (urine, oral fluid, or blood) for their patients. Aegis bills per test, typically covered by Medicare, Managed Medicaid, Commercial Insurance, and Workers' Compensation. Testing spans adherence monitoring, NPS detection, clinical blood testing, and infectious disease testing.

aegislabs.com
2Sports Anti-Doping Testing
TypeTransaction Fee
Description

Aegis provides Zero-Tolerance® drug testing services to professional sports organizations, colleges, universities, high schools, and amateur sports bodies. Revenue is generated per test or through contracted testing agreements.

aegislabs.com
3Biopharma / Molecular Diagnostic Services
TypeProfessional Services
Description

Aegis provides clinical trial services, pharmacogenetic testing, and other molecular diagnostic services to pharmaceutical companies, generating revenue through per-test fees or contracted service agreements.

Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Healthcare provider testing — per test basis
ModelOtherBilling cadencePay-as-you-go
Notes

No public pricing available. Testing is ordered by healthcare providers and typically billed through Medicare, Managed Medicaid, Commercial Insurance, or Workers' Compensation per-test.

aegislabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1PainComp
Description

Pain management adherence testing designed to assure complete care for individuals receiving treatment for chronic pain, testing for adherence with prescribed medications.

aegislabs.com
+6 more records
Core offering1 text field

Aegis Sciences Corporation operates a CLIA- and CAP-accredited forensic toxicology and healthcare laboratory that delivers definitive drug testing on urine, oral fluid, and blood specimens using LC-MS/MS technology. The company sells adherence monitoring panels (PainComp®, AcuRise ID™), novel psychoactive substances (NPS) testing, drug-drug interaction decision support (InterACT Rx), Zero-Tolerance® anti-doping testing, BioDetect, clinical blood testing, infectious disease testing, and biopharma/molecular diagnostic services to healthcare providers, sports organizations, public health agencies, and pharmaceutical clients through its CareEvolve ordering platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by drug-drug interactions, resulting in improved patient outcomes.
Product overview1 text field

Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory founded in 1990, providing science-driven drug testing and consulting services. The company offers a unified platform of clinical laboratory testing services with multiple branded products and modules. Core offerings include PainComp and AcuRise ID for adherence monitoring across pain management, mental illness, and substance use disorder; Novel Psychoactive Substances (NPS) testing with the proprietary NPS Insights Dashboard for real-time tracking; Kratom Alkaloids and Cannabinoids testing for emerging substances; InterACT Rx for drug-drug interaction management; BioDetect for bio-detection; Clinical Blood Testing; Sports Testing under the Zero-Tolerance brand; and Infectious Disease Testing. Additional services include Oral Fluid Testing and Biopharma Lab Services. CareEvolve serves as the client-provider ordering and practice management platform. Testing is performed using definitive LC-MS/MS methods on urine, oral fluid, or blood specimens.

Product and service3 records
1Aegis PainComp
CategoryAdherence Monitoring
Description

Adherence testing designed for individuals receiving treatment for chronic pain, providing definitive verification that patients are only taking prescribed medications and are not using non-prescribed or illicit drugs. Sold to pain management clinicians and practice groups as a standalone adherence monitoring service.

2Aegis AcuRise ID
CategoryAdherence Monitoring
Description

Adherence testing for clinicians treating mental illness and substance use disorder, providing objective measurement of medication adherence and assessment of non-prescription substances that may impact psychiatric symptoms or recovery. Sold to behavioral health, addiction medicine, and SUD treatment providers as a standalone adherence monitoring service.

3Novel Psychoactive Substances (NPS) Testing
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Aegis and QURE collaborated on InterACT Rx, a drug-drug interaction detection tool. Results showed physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs, resulting in improved patient outcomes. This partnership represents joint product development to enhance clinical decision support.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Quest Diagnostics is the largest U.S. clinical reference laboratory, providing routine and specialty diagnostic testing including pain management and substance abuse toxicology panels. It competes directly with Aegis for healthcare provider drug testing volumes and payer network inclusion.

TypeBroad incumbent
Description

Eurofins is a global laboratory services group providing clinical diagnostics, pharmaceutical testing, and forensic toxicology services. It competes with Aegis in clinical trial and biopharma lab services, and operates specialized toxicology and drug testing offerings comparable in scope.

TypeBroad incumbent
Description

Sonic Healthcare is an international clinical pathology and diagnostic services provider with U.S. operations including clinical toxicology and drug monitoring. It competes with Aegis for healthcare provider testing volume and has the scale advantages of a multi-region operator.

TypeDirect peer
Description

DrugScan (now part of IT&M) is a specialty clinical toxicology laboratory offering definitive drug and alcohol testing for pain management, addiction treatment, and occupational health — overlapping directly with Aegis's clinical drug testing business and customer segments.

TypeDirect peer
Description

Psychemedics is a specialty laboratory offering hair-based drug testing for workplace, legal, and sports applications. While Aegis uses LC-MS/MS on urine/oral fluid and Psychemedics uses hair, both compete for anti-doping and drug testing contracts in similar customer verticals.

TypeDirect peer
Description

Millennium Health is a specialty clinical laboratory focused on definitive drug testing, particularly urine drug monitoring for pain management, behavioral health, and substance use disorder — directly overlapping Aegis's PainComp and AcuRise ID target segments and provider base.

TypeEmerging player
Description

Myriad Genetics provides molecular diagnostic testing including pharmacogenomics that intersects with Aegis's biopharma and pharmacogenetic testing offering. While focused on hereditary cancer and women's health, its molecular diagnostics platform overlaps in clinical trial and personalized medicine services.

TypeBroad incumbent
Description

LabCorp is one of the two largest U.S. clinical reference laboratory networks, offering a broad menu of routine and esoteric clinical lab testing including toxicology and drug monitoring. It competes with Aegis on payer contracts and provider-direct drug testing but operates at far greater scale and breadth.

TypeDirect peer
Description

USDTL is a specialty forensic and clinical toxicology laboratory providing definitive drug testing using LC-MS/MS for substance use disorder, pain management, prenatal, and workplace testing — directly comparable in technology, methodology, and customer base to Aegis.

TypeDirect peer
Description

Cordant Health Solutions provides medication monitoring, toxicology screening, and behavioral health laboratory services for healthcare providers and criminal justice customers. It overlaps directly with Aegis in clinical drug testing, adherence monitoring, and substance use disorder segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aegis Sciences

Forensic Toxicology and Clinical Drug Testing Laboratory Servicesaegislabs.com

Aegis Sciences Corporation is a Nashville-based forensic toxicology and clinical laboratory that performs definitive LC-MS/MS drug and substance testing on urine, oral fluid, and blood for healthcare providers, sports organizations, biopharma companies, and public health agencies across the United States.

What Aegis Sciences does

Aegis Sciences Corporation is a privately held forensic toxicology and clinical laboratory founded in 1990 and headquartered in Nashville, Tennessee. The company performs definitive drug and substance testing on urine, oral fluid, and blood specimens using liquid chromatography-tandem mass spectrometry (LC-MS/MS) under CLIA and College of American Pathologists (CAP) standards, and serves a diverse set of customers including pain management providers, behavioral health and substance use disorder treatment providers, professional and amateur sports organizations, pharmaceutical companies, and public health agencies.

The company's product portfolio is organized around branded clinical offerings: PainComp and AcuRise ID for adherence monitoring; a continuously updated Novel Psychoactive Substances (NPS) testing menu aligned with CFSRE/SOFT recommendations; the NPS Insights Dashboard providing real-time national surveillance visualization; InterACT Rx for drug-drug interaction detection (co-developed with QURE); BioDetect; Kratom Alkaloids and expanded Cannabinoid testing; Clinical Blood Testing; Infectious Disease Testing; and the Zero-Tolerance anti-doping service operated out of the Wilma Rudolph Sports Testing Laboratory, where Aegis is the largest independent anti-doping laboratory in the U.S. serving more than 150 colleges, universities, high schools, and professional sports organizations. CareEvolve is the client-provider portal for test ordering and results delivery.

Aegis generates revenue on a per-test basis, billed primarily through Medicare, Managed Medicaid, Commercial Insurance, and Workers' Compensation, with the UnitedHealthcare Preferred Lab Network relationship expanding in-network access. Go-to-market is sales-led, directed at healthcare providers who order testing through the Aegis platform, supplemented by clinical education content, webinars, the NPS Insights Dashboard, and conference participation. In June 2025 the company completed a $170 million debt refinancing to support continued investment in laboratory infrastructure and service expansion.

Aegis Sciences firmographics

Firmographics
Name
Aegis Sciences
Legal name
Aegis Sciences Corporation
Website
https://aegislabs.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Aegis Sciences Corporation is a Nashville-based forensic toxicology and clinical laboratory that performs definitive LC-MS/MS drug and substance testing on urine, oral fluid, and blood for healthcare providers, sports organizations, biopharma companies, and public health agencies across the United States.
Ownership category
akta.pro rank

Aegis Sciences industry classification

Industry
Product category
Forensic Toxicology and Clinical Drug Testing Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAFAMAF
Toxicology & Therapeutic Drug Monitoring Laboratories
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGACAK
Clinical Trial Pharmacy & IMP Management at Site
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs

Keywords

  • Forensic toxicology laboratory
  • Clinical drug testing
  • Medication adherence monitoring
  • Novel psychoactive substances
  • Anti-doping testing services

Where Aegis Sciences is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Aegis Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical Drug Testing Services: Healthcare providers order definitive drug testing (urine, oral fluid, or blood) for their patients. Aegis bills per test, typically covered by Medicare, Managed Medicaid, Commercial Insurance, and Workers' Compensation. Testing spans adherence monitoring, NPS detection, clinical blood testing, and infectious disease testing.
  2. Sports Anti-Doping Testing: Aegis provides Zero-Tolerance® drug testing services to professional sports organizations, colleges, universities, high schools, and amateur sports bodies. Revenue is generated per test or through contracted testing agreements.
  3. Biopharma / Molecular Diagnostic Services: Aegis provides clinical trial services, pharmacogenetic testing, and other molecular diagnostic services to pharmaceutical companies, generating revenue through per-test fees or contracted service agreements.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goHealthcare provider testing — per test basis

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Aegis Sciences product offering

Product offering

Core offering

Aegis Sciences Corporation operates a CLIA- and CAP-accredited forensic toxicology and healthcare laboratory that delivers definitive drug testing on urine, oral fluid, and blood specimens using LC-MS/MS technology. The company sells adherence monitoring panels (PainComp®, AcuRise ID™), novel psychoactive substances (NPS) testing, drug-drug interaction decision support (InterACT Rx), Zero-Tolerance® anti-doping testing, BioDetect, clinical blood testing, infectious disease testing, and biopharma/molecular diagnostic services to healthcare providers, sports organizations, public health agencies, and pharmaceutical clients through its CareEvolve ordering platform.

Product overview

Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory founded in 1990, providing science-driven drug testing and consulting services. The company offers a unified platform of clinical laboratory testing services with multiple branded products and modules. Core offerings include PainComp and AcuRise ID for adherence monitoring across pain management, mental illness, and substance use disorder; Novel Psychoactive Substances (NPS) testing with the proprietary NPS Insights Dashboard for real-time tracking; Kratom Alkaloids and Cannabinoids testing for emerging substances; InterACT Rx for drug-drug interaction management; BioDetect for bio-detection; Clinical Blood Testing; Sports Testing under the Zero-Tolerance brand; and Infectious Disease Testing. Additional services include Oral Fluid Testing and Biopharma Lab Services. CareEvolve serves as the client-provider ordering and practice management platform. Testing is performed using definitive LC-MS/MS methods on urine, oral fluid, or blood specimens.

Differentiator

Problem solved

Functional benefit

Brands

  • PainComp: Pain management adherence testing designed to assure complete care for individuals receiving treatment for chronic pain, testing for adherence with prescribed medications.
  • AcuRise ID
  • Zero-Tolerance
  • InterACT Rx
  • NPS Insights Dashboard
  • BioDetect
  • Wilma Rudolph Sports Testing Laboratory

Products and services

  • Aegis PainComp Adherence testing designed for individuals receiving treatment for chronic pain, providing definitive verification that patients are only taking prescribed medications and are not using non-prescribed or illicit drugs. Sold to pain management clinicians and practice groups as a standalone adherence monitoring service.
  • Aegis AcuRise ID Adherence testing for clinicians treating mental illness and substance use disorder, providing objective measurement of medication adherence and assessment of non-prescription substances that may impact psychiatric symptoms or recovery. Sold to behavioral health, addiction medicine, and SUD treatment providers as a standalone adherence monitoring service.
  • Novel Psychoactive Substances (NPS) Testing

Quantifiable outcome

  • Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by drug-drug interactions, resulting in improved patient outcomes.

Companies that use Aegis Sciences

Customer profile

Named customers7 records

Segments6 records

Ideal customer profiles5 records

Aegis Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Aegis Sciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • QUREcoreStrategic or Co-development PartnerAegis and QURE collaborated on InterACT Rx, a drug-drug interaction detection tool. Results showed physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs, resulting in improved patient outcomes. This partnership represents joint product development to enhance clinical decision support.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Aegis Sciences competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is the largest U.S. clinical reference laboratory, providing routine and specialty diagnostic testing including pain management and substance abuse toxicology panels. It competes directly with Aegis for healthcare provider drug testing volumes and payer network inclusion.
  • Eurofins Scientific: Eurofins is a global laboratory services group providing clinical diagnostics, pharmaceutical testing, and forensic toxicology services. It competes with Aegis in clinical trial and biopharma lab services, and operates specialized toxicology and drug testing offerings comparable in scope.
  • Sonic Healthcare: Sonic Healthcare is an international clinical pathology and diagnostic services provider with U.S. operations including clinical toxicology and drug monitoring. It competes with Aegis for healthcare provider testing volume and has the scale advantages of a multi-region operator.
  • Laboratory Corporation of America (LabCorp): LabCorp is one of the two largest U.S. clinical reference laboratory networks, offering a broad menu of routine and esoteric clinical lab testing including toxicology and drug monitoring. It competes with Aegis on payer contracts and provider-direct drug testing but operates at far greater scale and breadth.

Direct peers

  • DrugScan: DrugScan (now part of IT&M) is a specialty clinical toxicology laboratory offering definitive drug and alcohol testing for pain management, addiction treatment, and occupational health — overlapping directly with Aegis's clinical drug testing business and customer segments.
  • Psychemedics Corporation: Psychemedics is a specialty laboratory offering hair-based drug testing for workplace, legal, and sports applications. While Aegis uses LC-MS/MS on urine/oral fluid and Psychemedics uses hair, both compete for anti-doping and drug testing contracts in similar customer verticals.
  • Millennium Health: Millennium Health is a specialty clinical laboratory focused on definitive drug testing, particularly urine drug monitoring for pain management, behavioral health, and substance use disorder — directly overlapping Aegis's PainComp and AcuRise ID target segments and provider base.
  • USDTL (United States Drug Testing Laboratories): USDTL is a specialty forensic and clinical toxicology laboratory providing definitive drug testing using LC-MS/MS for substance use disorder, pain management, prenatal, and workplace testing — directly comparable in technology, methodology, and customer base to Aegis.
  • Cordant Health Solutions: Cordant Health Solutions provides medication monitoring, toxicology screening, and behavioral health laboratory services for healthcare providers and criminal justice customers. It overlaps directly with Aegis in clinical drug testing, adherence monitoring, and substance use disorder segments.

Emerging players

  • Myriad Genetics: Myriad Genetics provides molecular diagnostic testing including pharmacogenomics that intersects with Aegis's biopharma and pharmacogenetic testing offering. While focused on hereditary cancer and women's health, its molecular diagnostics platform overlaps in clinical trial and personalized medicine services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aegis Sciences social profiles

Digital presence

Aegis Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aegis Sciences leadership team

Management profile

Number of profiles

Profiles7 records

Aegis Sciences funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aegis Sciences M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aegis Sciences

What does Aegis Sciences do?

Aegis Sciences Corporation operates a CLIA- and CAP-accredited forensic toxicology and healthcare laboratory that delivers definitive drug testing on urine, oral fluid, and blood specimens using LC-MS/MS technology. The company sells adherence monitoring panels (PainComp®, AcuRise ID™), novel psychoactive substances (NPS) testing, drug-drug interaction decision support (InterACT Rx), Zero-Tolerance® anti-doping testing, BioDetect, clinical blood testing, infectious disease testing, and biopharma/molecular diagnostic services to healthcare providers, sports organizations, public health agencies, and pharmaceutical clients through its CareEvolve ordering platform.

Is Aegis Sciences a public or private company?

Aegis Sciences is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aegis Sciences founded?

Aegis Sciences was founded in 1990. It employs 501 to 1,000 people.

Where is Aegis Sciences based?

Aegis Sciences is headquartered in Nashville, United States, in the North America region.

How does Aegis Sciences make money?

Three revenue lines are on record. Clinical Drug Testing Services are the primary driver. The others are sports Anti-Doping Testing and biopharma / Molecular Diagnostic Services.

Who are Aegis Sciences's main competitors?

Broad incumbents on record are Quest Diagnostics, Eurofins Scientific, Sonic Healthcare and Laboratory Corporation of America (LabCorp). Direct peers are DrugScan, Psychemedics Corporation, Millennium Health, USDTL (United States Drug Testing Laboratories) and Cordant Health Solutions. Myriad Genetics is listed as an emerging player.

Does Aegis Sciences have an API?

No public API is recorded for Aegis Sciences.

What industry is Aegis Sciences in?

Aegis Sciences's product category is Forensic Toxicology and Clinical Drug Testing Laboratory Services. Its primary akta.pro industry code is HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories, with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsJoel Galanter named interim CEO of Aegis SciencesFrank Basile has stepped down as CEO of Aegis Sciences, a Nashville-based company founded in 1990 at Vanderbilt University, with Joel Galanter named as interim CEO. The board has provided comment on Basile's departure, though the full details of the leadership transition are not available in this truncated content. No forward-looking statements or additional context about the reasons for the change are provided in the accessible portion of the article.Business Wire BlogAegis Sciences Names Joel Galanter Interim CEOAegis Sciences Corporation has named Joel Galanter as interim CEO, replacing Frank Basile. Galanter has an extensive background in the company's operations and industry-wide expertise, and plans to focus on growth and enhancing diagnostic testing services amid ongoing challenges related to the opioid epidemic.FinancialContent Business PageAegis Sciences Names Joel Galanter Interim CEOAegis Sciences Corporation has appointed Joel Galanter as Interim CEO, replacing Frank Basile who led the company since 2017. Galanter brings more than a decade of senior executive experience at Aegis, having overseen legal, regulatory, governmental affairs, and corporate governance functions since 2013. The board expressed confidence in Galanter's leadership as the company pursues its next phase of strategic growth.PharmiWeb.comAegis Sciences Corporation Announces Updates for NPS TestingAegis Sciences Corporation, a Nashville-based healthcare testing laboratory, announced its second bi-annual update to its novel psychoactive substance (NPS) testing menu for Q2 2025. The update incorporates recommendations from the Center for Forensic Science Research and Education (CFSRE), adding new categories including semi-synthetic cannabinoids and designer compounds such as Spirochlorphine and Ethylbromazolam. The company stated that these additions aim to equip clinicians with improved detection capabilities for emerging substances in the drug supply.Business Wire BlogAegis Sciences Corporation Announces Updates for NPS TestingAegis Sciences Corporation announced its second bi-annual update to its novel psychoactive substance (NPS) testing menu, incorporating the Center for Forensic Science Research and Education's (CFSRE) tier one and tier two scope recommendations for Q2 2025. The update adds new categories including "Semi-synthetic Cannabinoids" and "Miscellaneous," along with specific compounds such as Spirochlorphine (a designer opioid) and Ethylbromazolam (a designer benzodiazepine). According to company executives, these additions are designed to help clinicians detect emerging substances in the drug supply and support more accurate patient care decisions.AegislabsAegis Sciences Corporation Announces Successful $170 Million Debt RefinancingAegis Sciences Corporation completed a $170 million debt refinancing, advised by CoveView Advisors, with new debt investors led by Kayne Anderson. Abry Partners provided incremental growth equity capital, and Aegis retains an undrawn revolving credit facility for future investments.Business Wire BlogAegis Sciences Corporation Launches MedProtectCDM to Transform Medication Adherence and Safety Monitoring for Chronic ConditionsAegis Sciences launched MedProtectCDM, an oral fluid-based tool to detect medication nonadherence and drug interactions for chronic conditions. Studies show clinicians using it were 50.4 times more likely to recognize nonadherence and 26.9 times more likely to identify drug interactions. The tool aims to reduce hospitalizations and improve patient outcomes.PR NewswireAegis Sciences Corp Selects Quadax as a Revenue Cycle Management Partner for Their Laboratory BusinessQuadax Inc. partnered with Aegis Sciences Corp to manage revenue cycle management for its laboratory services, including insurance eligibility, third-party and patient billing, and denial management. Aegis went live with the suite of Quadax services to improve transparency and operational performance.BioSpaceAegis Sciences Corporation Acquires HealthTrackRx’s Toxicology Business UnitAegis Sciences Corporation acquired HealthTrackRx's toxicology business unit, expanding its clinical toxicology testing services. HealthTrackRx, a PCR-based infectious disease lab, has shifted focus to infection detection, making toxicology a declining portion of its portfolio. Aegis aims to provide comprehensive testing to more providers.RevoadaPatient portal.aegislabs.com What Is The Patient Portal?Aegis Laboratories' patient portal provides virtual medical services including appointments, screenings, and prevention plans. It launched a merged test for Influenza A/B and SARS-CoV-2 during the pandemic. The portal also offers mental health, chronic disease, and anti-doping services.